Billing & Payments
Notice of Compliance
MPLN adheres to the guidelines set forth by CMS and Commercial insurance plans. Please see our Notice of Compliance below for additional information regarding payer requirements and client billing of testing.
MPLN adheres to the guidelines set forth by CMS and Commercial insurance plans. Please see our Notice of Compliance below for additional information regarding payer requirements and client billing of testing.
Code Category/Description | 2018 MolDX CPT Code Range |
Tier I | 81161-81383 |
Tier 2 | 81400-81408 |
Genomic Sequencing Procedures | 81410-81471 |
Molecular Multianalyte Assays (MAAA) | 81490-81595 |
MAAA Admin Codes | All Codes |
Immunology | 86152-86153 |
Microbiology | 87505-87507, 87631-87633, 87149-87150 |
PLA | All Codes |
Cytology | 88120-88121 |
Not otherwise classified (NOC) | 81479, 81599, 84999, 85999, 86849, 87999, 88199, 88299, 88399, 89398 |
To access the Z-codes for our tests, each hospital or laboratory organization must register with the DEX Diagnostics Exchange. The website to register in the Diagnostics Exchange is https://app.dexzcodes.com. To complete registration, you will need your NPI and CLIA #s. The instructions for submitting a sharing request are outlined below:
How to make a sharing request
For MPLN to bill an insurance company or third party administrator, be sure to include the following information on the requisition form:
Patients are responsible for co-payments, deductibles and/or outstanding balances not covered by insurance. If your patient has a question about their laboratory bill, he or she is welcome to call MPLN directly.
MPLN is a member of insurance networks across the country. Below you will find the current list of our participating insurance providers.
The Current Procedural Terminology (CPT) Codes that MPLN provides in its reports and other literature are based on our interpretation of CPT code requirements and are subject to review and change. It is our clients’ responsibility to verify the accuracy of the CPT. CPT is a registered trademark of the American Medical Association.
Contact our client services team today.
Beyond informing drug target discovery, validation, and clinical development, it uncovers critical genetic markers that drive disease progression and influence individual treatment responses. This empowers healthcare professionals to create more precise, tailored treatment plans, optimizing medical management based on each patient’s genetic profile.
DNA Solutions – WGS*, WGMS*, WES*, TSO-500 Comp, Pillar OncoReveal
RNA Solutions – Total RNA-Seq*, RNA exome*, mRNA*
Liquid Biopsy Solutions – TSO-500 ctDNA, PGDx elio™ plasma complete*
*Offered through fully accredited partner laboratories.
Our advanced technology enables simultaneous visualization of single or multiple biomarkers within the same tissue section, delivering comprehensive insights and precise diagnostics. With unmatched expertise and cutting-edge technology, our team supports you in understanding complex tissue microenvironments, aiding patient stratification and treatment response prediction.